Noble Capital Markets Initiates Research Coverage on Newsmax (NMAX)
Noble's Equity Research Analyst Michael Kupinski launched coverage on Newsmax today with his report titled "Riding the Red Wave"
Noble Capital Markets Initiates Research Coverage on Greenwich LifeSciences Inc. (GLSI)
Noble’s Equity Research Analyst Robert LeBoyer launched coverage today with his report titled “Initiating Coverage With An Outperform Rating and $45 Price Target” The full report can be viewed, at no cost, on Channelchek.com.
Noble Capital Markets Initiates Research Coverage on Titan International (TWI)
Noble’s Equity Research Analyst Joe Gomes launched coverage on Titan International (TWI) with his report titled "An Off Road Leader; Initiating Research Coverage"
Noble Capital Markets Initiates Research Coverage on Superior Group of Companies (SGC)
Noble’s Equity Research Analyst Michael Kupinski launched coverage on Superior Group of Companies today with his report titled “An Investment Opportunity In Keeping With Its Name"
Noble Capital Markets Initiates Research Coverage on Sky Harbour Group (SKYH)
Noble’s Equity Research Analyst Patrick McCann launched coverage on Sky Harbour Group today with his report titled "Initiation of Coverage: A Long Cashflow Growth Runway"
Noble Capital Markets Initiates Equity Research Coverage on Nicola Mining Inc. (HUSIF)
Noble’s Equity Research Analyst Mark Reichman launched coverage today with his report titled “Multiple Avenues for Value Creation Supported by Operational Cash Flow”
Noble Capital Markets Initiates Equity Research Coverage on The ONE Group Hospitality (STKS)
Noble’s Equity Research Analyst Joe Gomes launched coverage on The ONE Group Hospitality today with his report titled “A Leader in Vibe Dining, Initiating Research Coverage”
Noble Capital Markets Initiates Equity Research Coverage on MariMed (MRMD)
Noble Capital Markets Senior Research Analyst Joe Gomes has initiated equity research coverage on MariMed (MRMD) with his report titled "A Cannabis Brands Company; Initiating Coverage"
Noble Capital Markets Initiates Equity Research Coverage on Gyre Therapeutics (GYRE)
Noble Capital Markets has initiated equity research coverage on Gyre Therapeutics (GYRE) with today's report, titled "Initiation of Coverage: Focused On Fibrosis"
Noble Capital Markets Initiates Equity Research Coverage on Nutriband (NTRB)
Noble’s Equity Research Analyst Robert LeBoyer launched coverage on Nutriband today with his report titled “Initiating Coverage With An Outperform Rating And $13 Price Target”
Noble Capital Markets Initiates Equity Research Coverage on Zomedica Corp. (ZOM)
Noble’s Equity Research Analyst Rober LeBoyer launched coverage on Zomedica Corp. today with his report titled "Improving Pet Health and Veterinary Practices - Initiating Coverage With An Outperform Rating"
Noble Capital Markets Initiates Equity Research Coverage on Perfect Corp. (PERF)
Noble’s Equity Research Analyst Patrick McCann launched coverage on Perfect Corp. today with his report titled "An AI Company Positioned to Accelerate Revenue Growth"
